To elucidate the molecular basis of BMP4-induced differentiation of human pluripotent stem cells (PSCs) toward progeny with trophectoderm characteristics, we produced transcriptome, epigenome H3K4me3, H3K27me3, and CpG methylation maps of trophoblast progenitors, purified using the surface marker APA. We combined them with the temporally resolved transcriptome of the preprogenitor phase and of single APA+ cells. This revealed a circuit of bivalent TFAP2A, TFAP2C, GATA2, and GATA3 transcription factors, coined collectively the "trophectoderm four" (TEtra), which are also present in human trophectoderm in vivo. At the onset of differentiation, the TEtra factors occupy multiple sites in epigenetically inactive placental genes and in OCT4. Functional manipulation of GATA3 and TFAP2A indicated that they directly couple trophoblast-specific gene induction with suppression of pluripotency. In accordance, knocking down GATA3 in primate embryos resulted in a failure to form trophectoderm. The discovery of the TEtra circuit indicates how trophectoderm commitment is regulated in human embryogenesis.
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trophectoderm | trophoblast | BMP4 | hESC | differentiation T he earliest cell fate commitment event that takes place during eutherian embryogenesis is the bifurcation of totipotent cells into the inner cell mass that generates the fetus, and trophectoderm (TE) precursors that give rise to the chorion and subsequently the fetal portion of the placenta (1) . Studies of TE specification in the mouse revealed the importance of the transcription factors (TFs) Tead4 (2, 3), Cdx2 (4, 5) , Eomes (4, 6), Gata3 (7), and AP-2γ (Tfap2c) (8, 9) . Further differentiation of the precursors involves TFs such as the placenta morphogenesis master regulator Gcm1, Elf5, which promotes self-renewal of mouse trophoblast stem cells (TSCs), and Hand1 and Mash2 that regulate giant cell and spongiotrophoblast development, respectively (10) (11) (12) (13) . The expression of Cdx2 in the outer layer cells of the embryo, which are destined to become trophoblasts, is thought to antagonize pluripotency by interfering with Oct4 autoregulation (5) . In accordance with these key roles, overexpression of Tead4, Cdx2, Eomes, or Gata3 in mouse embryonic stem cells (ESCs) is sufficient to drive them toward the TE fate (5, 7, 14) . Recently, it has also been shown that ectopic expression of Tfap2c, Gata3, Eomes, and either Myc or Ets2 converts mouse fibroblasts to functional trophoblast stem-like cells (15) (16) (17) .
The molecular mechanism of TE specification in humans has not been elucidated, but expression studies have shown that orthologs of some of the key TFs implicated in mouse TE development, including CDX2, TFAP2C, GCM1, and GATA3, are found in human TE progenitors at the blastocyst stage (18) (19) (20) (21) . The early expression of TFAP2 TFs could have been inferred from deregulation of their target genes in cases of placental dysfunction (22) . Other mouse TFs, however, like Eomes and Elf5, were not unequivocally assigned to the TE lineage in human embryos (23) .
Human ESCs (hESCs) and induced pluripotent stem cells (iPSCs) can differentiate into trophoblast-like cells by treatment with BMP4, BMP5, BMP10, or BMP13 (24) (25) (26) (27) (28) (29) . Although these morphogens were not initially implicated in trophoblast development in the mouse (30, 31) , it was recently found that components of the BMP signaling pathway are indeed differentially expressed in TE-fated cells immediately following the first wave of asymmetric divisions in mouse embryos, and that BMP signaling is required for development of mouse TE in vivo (32) . The treatment of human ESCs by BMPs also gives rise to mesoderm lineages, but this process, unlike derivation of trophoblasts, is known to be Wnt dependent (33) .
Exposure of human ESCs and iPSCs (collectively PSCs) to BMPs triggers induction of a broad cohort of TFs including CDX2, GATA2, GATA3, TFAP2A, TFAP2C, MSX2, SSI3, HEY1, GCM1, and others, the majority of which by analogy to mouse
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knowledge could be considered candidate factors involved in human TE specification (29, 34) . However, it has yet to be determined which of these TFs actually participate in the initial specification of human trophoblast progenitors, how the TFs are configured in a circuit that drives further trophoblast development by transcription of placenta-specific genes, and to what extent this network governs primate TE specification in vivo.
The colocalization of the transcription promoting and inhibiting trimethylation modifications on lysine 4 and 27 of the histone H3 tail, namely H3K4me3 and H3K27me3, respectively, contributes to transcriptional poising of developmental genes in ESCs (35, 36) . Upon differentiation and depending on the lineage, the H3K4me3 mark dominates the expressed genes that lose the H3K27me3 mark, and conversely, the H3K27me3 mark is enhanced and the H3K4me3 mark is reduced in nonexpressed genes. These bivalent genes harbor cytosine-guanine dinucleotide (CpG)-dense promoter regions [high-CpG promoters (HCPs)] that are silenced by CpG methylation (37) . Interestingly, a distinct class of developmental genes does not exhibit bivalency in ESCs and is characterized by low presence of CpGs in promoters [low-CpG promoters (LCPs)] (36). The mode of activation and repression of this class, which is thought to include tissue-specific regulators and structural genes, is considered distinct from that of HCP genes (38) .
We have previously identified a panel of cell surface markers, including aminopeptidase A (APA) (or CD249/Ly-51), LIFR, EGFR, and CD117 (c-kit) that are expressed by a trophoblast progenitor population that emerges as early as 48 h after treatment of human PSCs by BMP4. We showed that sorted APA+, but not APA− cells, display cytotrophoblast characteristics and the capacity to further differentiate into multinucleated fused syncytiotrophoblast-like cells, and to express placental hormones in vivo (26) . These surface markers therefore could be instrumental for purifying trophoblast progenitors and discovering mechanisms that regulate initial specification and differentiation along this lineage.
Here, we addressed these questions by transcriptome and epigenome analyses of purified BMP4-treated human ESC-derived trophoblast-fated progenitors as bulk population and single cells. We coupled these data to temporally resolved transcriptome changes that occur in the cells before the progenitors emerge. Our results support the identification of the human PSC-derived trophoblast progeny as TE, rather than extraembryonic mesoderm (33) . Moreover, we discovered a TF circuit that could explain the coupling of TE specification with suppression of pluripotency, a finding that was supported by mapping the genome-wide binding sites of the TFs, and by the results of functional manipulation of these TFs in human ESCs in vitro and in primate embryos in vivo. Our results also revealed the modes of epigenetic regulation that govern gene induction and suppression along the differentiation axis of human PSCs to trophoblasts.
Results
The Transcriptome of Human Trophoblast Progenitors. To identify cell-intrinsic mechanisms that govern human TE specification in vitro, we used the previously characterized cell surface marker APA (ENPEP), which marks trophoblast progenitors that differentiate from human ESCs upon constant exposure to BMP4 (26) . The APA+ cell population emerged, peaked, and leveled out when 70-90% of the cells became positive, at differentiation days 2, 3, and 4, respectively ( Fig. 1 A and B) . Further culturing using this condition led to production of secreted CG (hCG), a pregnancy hormone expressed by trophoblasts in utero (39) (Fig.  1C) . This protocol performed equally well in KnockOut serum replacement (KSR)-based and B27-based media (Fig. S1) .
To characterize key genes involved in the differentiation of human trophoblast progenitors, we sorted the top 20% brightest APA+ and dimmest APA-cell populations after 60 h (2.5 d) of differentiation, around the time when the size of the APA+ population grows exponentially. To set a baseline for gene expression levels, we sorted the SSEA-5+ cell population from undifferentiated cultures (which includes ∼95% of the cells).
This removes spontaneously differentiated cells that can obstruct analysis of cell-intrinsic properties (40) . Lineage assessment of these cell populations by qPCR before global transcriptomics analysis indicated a transition from pluripotency to TE fate in the APA+ population evident by OCT4 down-regulation and a reciprocal CDX2, GCM1, and ENPEP (APA) up-regulation (Fig. S2A) . Moreover, in the APA− population, we noticed an up-regulation of key mesoderm genes and surface markers, including T, GSC, ROR2, and CD13, as well as lower enrichment of trophoblast genes, for example, GCM1, indicating that this population consisted of primitive streak-like progenitors and possibly cells in pre-APA phase (Fig. S2A) .
Next, we globally analyzed differentially expressed (DE) genes in the APA+, APA−, and SSEA-5+ cell populations using Affymetrix oligonucleotide microarrays ( Fig. S2B and Dataset S1). Comparing APA+, APA−, and SSEA-5+ profiles, we noted ∼700 down-and ∼1,000 up-regulated transcripts ( Fig. 1 D and E,  respectively) . The cohort of the down-regulated genes included the pluripotency circuitry members SOX2, OCT4, and NANOG (Fig. 1D) . Importantly, tissue association analysis of the genes that were up-regulated in the APA+ population identified trophoblast and placental tissues as the most overrepresented ( Fig. 1F ; a similar signature was observed when comparing the APA+ and APA− cell populations; Fig. S2C ). This shows the relevance of the APA+ cell population for identifying key human TE genes. To substantiate this claim, we compared the up-regulated gene set of the APA+ population with the genes that are enriched in human embryonic mural trophoblasts (19) , and demonstrated an overlapping set of TFs including GCM1, TP63, VGLL1, GATA2, GATA3, and TFAP2C, as well as the surface marker ENPEP (APA), which was collectively annotated as trophoblast/placenta specific with high confidence (Fig. S2D) . Finally, the enrichment of CDX2 and ELF5 in the APA+ cell population (Fig. S2A ) is also consistent with commitment to TE fate (5, 13) .
To assess the degree of heterogeneity in the APA+ population, we performed global RNA sequencing (RNA-seq) of ∼350 individually sorted APA+ and undifferentiated cells. Analysis of this dataset confirmed that the APA+ population is essentially homogenous, except for fewer than 10% of the cells that clustered with undifferentiated cells (Fig. 1G and Fig. S3 ). Importantly, significantly up-regulated genes in single APA+ cells exhibited associations with trophoblast and placental tissues (Fig. 1H) , similarly to the bulk APA+ cell population (Fig. 1F) . Taken together, we concluded that BMP4 treatment of human ESCs leads to the specification of APA+ progenitors that, on the gene expression level, resemble human TE progenitors in vivo and lack pluripotency features, and that the transcriptional network of these early progenitors is enriched for factors which were previously found to be important in mouse TE development. To analyze posttranslational histone modifications that underlie human trophoblast progenitor specification and pluripotency shutdown, we used sorted APA+, APA−, and SSEA-5+ cell populations (matched samples of Fig. 1 ) to perform chromatin immunoprecipitation and deep sequencing (ChIP-seq) of H3K4me3-and H3K27me3-bound DNA fragments (using validated antibodies; Fig.  S4 ). Comparing APA+ and SSEA-5+ populations, we found that the redistribution of H3K4me3 or H3K27me3 monovalent, bivalent (both marks present), and H3K4me3/K27me3 double-negative genes was markedly different between up-and down-regulated genes ( Fig. 2 A and B, representative maps in Fig. 2E ). While close to 65% of the genes that were bivalent in undifferentiated SSEA-5+ cells became predominantly H3K4me3 monovalent (by losing the H3K27me3 mark) in the case they were up-regulated, there was a little change in bivalency for genes that are downregulated. Also, only around 25% of the genes from the H3K4me3 class became bivalent when they are down-regulated. Taken together, this indicates that transcriptional changes often precede changes in histone modifications, both in the direction of gene induction and repression. This conclusion is supported by a group of up-regulated genes that maintained the H3K4me3/K27me3 double-negative phenotype ( Fig. 2A) .
To gain specific insights into the relationship between chromatin states and transcriptional regulation in TE progenitors, we next focused on transcription factors/cofactors (TFs collectively) that were DE between the APA+ and the SSEA-5+ cell population. With respect to the up-regulated TFs, we found that orthologs of key mouse trophoblast-related TFs belong to the bivalent or double-negative class in undifferentiated cells ( Fig. 2 C and E and Dataset S2). This included CDX2, GATA3, TFAP2C and GCM1, VGLL1, TP63, and ELF5, respectively. Moreover, a cohort of genes that is specific for trophoblast and placental tissues, including steroid sulfatase (STS) and solute carriers SLC13A4 and SLC8A1, was found in the double-negative class (Fig. 2C ). TFs that were down-regulated in the APA+ cell population, including SOX2, NANOG, and OCT4 in most part belonged to the H3K4me3-monovalent class in undifferentiated cells (Fig. 2D) . Intriguingly, NANOG and OCT4 were among the rare genes in this class that lost H3K4me3 mark without gaining H3K27me3 mark in the APA+ cells ( Fig. 2 B and E).
Taken together, this argues that distinct cohorts of regulators which participate in the process of human trophoblast specification are held in divergent chromatin states in undifferentiated human ESCs: one cohort includes bivalent TFs that become predominantly H3K4me3 monovalent in trophoblast progenitors, and a second cohort comprises trophoblast-specific TFs and other genes that are mostly double negative. Interestingly, the initial transcriptional up-regulation of the latter group took place without H3K4me3 histone mark changes. (Fig. 3C ). Read coverage plots of representative genes from these clusters, including GATA3, CDX2, and GCM1, respectively, as well as of OCT4 are depicted in Fig.  3B . Next, we analyzed the TFs from each group with respect to overrepresented classes of histone modifications in undifferentiated SSEA-5+ cells. This showed that early genes were predominantly bivalent, while the late genes tend to be (although not reaching statistical significance) H3K4me3/K27me3 double negative and bivalent (Fig. 3D ). The cluster of the intermediate genes did not exhibit a specific overrepresentation of any histone class. While inspecting the TFs from the three groups, we noted that many of the genes that had the highest induction amplitudes (>32-fold at the given time points) are human orthologs of genes that had been previously implicated in mouse TE development (Fig. 3E) . This included bivalent (in SSEA-5+ cells) early TFs, namely GATA2, GATA3, TFAP2A, and TFAP2C (the latter exhibited only 10-fold up-regulation), which have known TEspecific functions (7, 9, (41) (42) (43) (44) ; intermediate-group bivalent TFs, HAND1 and CDX2, which are essential for placental development (4, 11); and late H3K4me3/K27me3 double-negative placental TFs, GCM1, VGLL1, and TP63 (45). This further Fig. 1 D and E, respectively) . TFs are listed on the side. An Inset in C shows double-negative non-TF genes that were significantly associated with placental tissues (Genomatix). (E) Representative histone mark coverage profiles that correspond to bivalent (GATA2, GATA3, TFAP2C), monovalent H3K4me3 (ARID3A, OCT4) and H3K27me3 (TFAP2B, CDX2), and double-negative (GCM1) loci in the SSEA-5+ cells. The y axis was normalized for each condition/histone modification combination across all genes.
strengthens the notion that the APA+ cell population represents bona fide early TE progenitors. The expression of MSX2 from the early group was not analyzed further in this context because its early induction is common to other early progenitors (Fig.  S5B) . Analysis of GATA2, GATA3, TFAP2A, and TFAP2C in single cells, as well as immunocytochemistry of the respective proteins, indicated that this TE phenotype represents the intrinsic properties of individual cells (Fig. 3F and Fig. S5C) .
High-and low-CpG island promoters (HCPs, LCPs) have been correlated with early embryonic or tissue-specific gene expression, respectively (38) . To determine whether the methylation status of the HCP and LCP changes during APA+ progenitor specification, we performed a genome-wide analysis of CpG methylation. Surprisingly, we could not detect significant changes of the methylation states in CpGs of bivalent and H3K4me3/K27me3 double-negative TF genes, which are respectively low and high, comparing the APA+, APA−, and undifferentiated SSEA-5+ cell population (Fig. 3G) .
Based on these data, we hypothesized that early TE progenitors are specified rather quickly and exit the state of pluripotency by an input from a group of early-response TFs (induced by Global Mapping of TFAP2A/C and GATA2/3 TF-Bound Loci. To delineate the binding landscape of the early TFs in TE progenitors, we used human ESCs that were differentiated for 72 h to perform ChIP-seq of GATA2, GATA3, TFAP2A, and TFAP2C. De novo search produced motifs that closely resemble those previously published for these factors (Fig. 4A) . Next, listing of putative target genes, according to TF binding in −3.5/+5 kb around the transcription start site (TSS), revealed that when more TFs were bound, the correlation to transcriptional up-regulation was higher. Conversely, the transcriptional down-regulation was negatively correlated with the number of bound TFs (Fig. 4B) . Moreover, GATA3 exhibited the broadest potential of synergy with the other three TFs because it coincided with the other TFs more frequently (Fig. 4C) . Taken together, this suggests that binding of GATA2/3, TFAP2A/C is predominantly gene activating, and that GATA3 if the chief member of the four TFs, which collectively promote trophoblast differentiation. Indeed, of the 204 genes that were bound by the four TFs, 122 (60%) were up-regulated in the APA+ cell population (Dataset S4). This includes 11 TFs, among them CDX2 and ANKRD1, which have been implicated in TE specification, and GCM1 that is bound by three TFs (Fig. 4 D and E) . Importantly, CDX2 displayed potential binding of all four TFs in the first intron (Fig. 4E) , which is in line with the previous reports showing that the binding of GATA3 and TFAP2C to the first intron of Cdx2 in mouse TSCs activates its transcription (46, 47) . Interestingly, this intronic site is occupied by OCT4 and NANOG in undifferentiated human ESCs (Fig. S6B) . The up-regulated non-TF genes that exhibited binding of the four TFs, included ENPEP, STS, VTCN1, and other placenta-specific genes (Fig. 4D) . In addition, we noted in ∼50% of the possible cases, autofactor or cross-factor interactions between the TFs GATA2/3 and TFAP2A/C (Fig. S6A) . Strikingly, in the very few genes where promoter CpG demethylation did take place during the differentiation from SSEA-5+ to APA− and APA+ populations, these genes were bound by the four TFs (asterisklabeled genes in Fig. 4D) .
Finally, although only two down-regulated TFs were bound by GATA2/3 and TFAP2A/C, this binding is likely important for down-regulation of pluripotency, as it took place in the first intron of OCT4, and in JADE1, which promotes histone acetylation and was implicated in embryogenesis (48) (Fig. 4 D and E) . Taken together, these data indicate that GATA2/3 and TFAP2A/C TFs form a feedforward network that regulates pluripotency and TE genes.
Functional Validation of GATA3 and TFAP2A in TE Specification. To functionally analyze the roles of GATA2/3 and TFAP2A/C in human TE differentiation, we manipulated the expression of the one factor from either pair that is more likely to have a broader regulation. We chose GATA3 because it exhibited the highest cooccupancy potential among the four TFs (Fig. 4C) , and TFAP2A since it was induced to a higher extent than TFAP2C (Fig. 3E) . We used the HUES9 human ESC line that carries an inducible Cas9 cassette (iCRISPR) (49) to delete the boundary of the first intron and the second exon in both genes (325 and 149 bp, respectively). Analysis of differentiated clones (72-h BMP4), harboring homozygous deletions, demonstrated complete absence of GATA3 protein in two clones and of TFAP2A in one clone, and faint bands of TFAP2A in additional two clones (likely due to residual heterozygous or wild-type cells) (Fig. 5A) . We observed that, while the knockout (KO) of GATA3 led to a drastic reduction in the number of APA+ progenitors (Fig. 5 B and C) and hCG levels (Fig. 5E ), which were comparable to undifferentiated cells, TFAP2A KO exhibited a much milder effect, leading to ∼30% reduction in the number of APA+ progenitors (Fig. 5 B and C) . Next, we analyzed the expression of OCT4 and early, intermediate, and late group up-regulated genes that overlapped between the time course induction and enrichment in the APA+ population (Fig. 3D ). In accordance with the direction of regulation during trophoblast differentiation, the up-regulation of GCM1 and VGLL1 significantly diminished and OCT4 increased in the GATA3 −/− and TFAP2A −/− clones that were treated by BMP4 compared with isogenic cells, but TP63 did not show a clear pattern of deregulation, at least not at the 72-h time point (Fig. 5D) . Unexpectedly, CDX2 expression increased more in the KO clones compared with isogenic control cells. Interestingly, the effects of the KOs on the other GATA/TFAP2 TFs did not follow an obvious pattern; GATA2 up-regulation decreased, TFAP2A increased, and TFAP2C did not show significant change in the GATA3 −/− clones, and in the TFAP2A −/− clones the expression of the other three TFs was not significantly altered ( 5D). We postulate that this is due to the complex web of interactions between the GATA and TFAP2 TFs (Fig. S6A) .
To substantiate the central function of GATA3 in TE specification, we analyzed the outcome of GATA3 overexpression in human ESCs cells (Fig. 5F ). This led to a phenotype that closely mimicked 72 h of BMP4 treatment, including the appearance of APA+ progenitors (albeit to a lesser extent), and the up-regulation of GATA2/ 3, TFAP2A/C, CDX2, and GCM1, as well as the down-regulation of OCT4 (Fig. 5 G and H) . Finally, to validate the role of GATA3 in primate development in vivo, we knocked down its expression in rhesus macaque embryos. We injected zygotes with morpholino antisense oligonucleotides and monitored the development of the embryos (Fig. 5 I-L) . While control noninjected embryos reached the blastocyst stage, with a typical frequency of macaque embryos in vitro of ∼30%, GATA3 knockdown led to a failure of blastocyst formation and an embryonic arrest at 32-cell/morula stage (Fig. 5 J-L) . These results suggest that GATA3 is vital for TE specification and embryonic development in primates.
Discussion
In this study, we provide multiple lines of evidence that BMP4 treatment of human ESCs promotes differentiation of trophoblastlike progeny that highly resembles human TE progenitors in vivo. We find that, when the cells exit from the state of pluripotency under this condition, mesendodermal commitment can be detected in the fraction of cells that do not express the cell surface marker APA (Fig. S1 ). APA had been previously characterized as a trophoblast-specific marker, and sorted APA+ cells were shown to give rise to placental-like tissues upon engraftment in vivo (26) . More recently, APA (ENPEP) was classified as TE-specific based on its expression in preimplantation human embryos (23, 50) . We establish here that gene expression analysis of the APA+ cells reliably classifies them as rather homogenous based on single-cell RNA-seq data, and combined -omics datasets that we produced show that the APA+ population has a pronounced trophoblast gene signature. For example, recently published criteria for defining human mononuclear trophoblasts (39) are fully met by the APA+ cells with respect to expression of marker genes (e.g., TFAP2C, GATA3, KRT7, ELF5). We do not, however, detect hypomethylated CpGs in the ELF5 promoter at day 3 APA+ progenitor state, arguing that the epigenetic remodeling at this locus begins at a later stage. Indeed, Lee et al. have assessed methylation changes at day 6 of BMP4 treatment. Additionally, we find that APA+ cells express the majority of the trophoblastspecific TFs from human mural trophoblasts (19) , as well as TEenriched genes characterized in human preimplantation embryos, including GATA3, CDX2, KRT18, DAB2, EFNA1, PPARG, and TEAD3 (23, 50) . Interestingly, three putative TE-specific markers proposed by Blakeley et al.-PLAC8, CLDN10, and TRIML1-were not detected as up-regulated in the APA+ cells. PLAC8 and CLDN10 were transiently up-regulated in bulk BMP4-treated cells from 8 to 24 h and from 24 to 48 h, respectively, arguing that they are not relevant for classifying trophoblasts in vitro, at least using the BMP4 protocol. Overall, based on the gene expression similarities, we are confident to claim that APA marks progenitors closely resembling human embryonic TE, making these cells a suitable model for studying TE progenitor development.
Our combined analysis highlighted three groups of genes with early, intermediate, and late up-regulation phases. We hypothesized that TFs displaying strong induction at the earliest time point of 8 h and persistent expression at least until the progenitors emerge on day 2.5 of differentiation, could be crucial for governing the transition from pluripotency to the trophoblast fate. Here, we propose that the identified set of four genes-GATA2, GATA3, TFAP2A, and TFAP2C-are likely to be the earliest drivers of the trophoblast specification in human ESCs. We named them the trophectoderm four ("TEtra"). Although all four factors have been implicated in the trophoblast development in mouse, and the GATA2-GATA3 redundancy was demonstrated (17, 51) , it is important to point out that the earliest known TFs induced during murine TE development-Tead4 and Klf5-were not found to be induced in our analysis (for review of mouse TE commitment, see ref. 52 ). Our investigation of the TEtra's chromatin occupancy revealed with high confidence gene-activating binding to the promoters of trophoblast-specific genes from all temporal groups-early (Fig.  6A) , intermediate (CDX2), and late (GCM1, VGLL1, TP63, STS, and ENPEP) (3, 12, 45, (53) (54) (55) . In line with the reports of refs. 56 and 57, we found that one member of TEtra-GATA3-exhibited certain characteristics of a "pioneer factor." Its promoter was the only one not bound by any other TEtra member, while it occupied the promoters of all of the other TEtra members (except its own, Fig. S6A ). In addition, it showed the highest degree of chromatin co-occupancy the with other TEtra members (Fig. 4C) . On the functional level, ablation of GATA3 in human ESCs and in primate embryos in vivo completely abolished the formation of TE progenitors, while overexpression of GATA3 in human ESCs produced a phenotype that closely mimics that of BMP4 treatment ( Fig. 5 G  and H) . Overall, this leads us to postulate that GATA3 occupies the very top of the TEtra hierarchy.
The chromatin occupancy analysis showed that GATA2, is bound by the three other TEtra factors and itself, pointing to its place at a step lower in the TEtra hierarchy compared with GATA3 (Fig. 6A) . Interestingly, while we observed a significant decrease of GATA2 up-regulation in the GATA3 KO BMP4-treated cells, others have reported an opposite effect of Gata3 knockdown in mouse and rat TSCs (58) . This highlights possible interspecies differences in GATA factor connectivity, which are expected according to studies showing the evolutionary plasticity of developmental gene regulatory network architectures (59) . TFAP2C was also bound by three factors, except GATA2, while TFAP2A, only by GATA3 and TFAP2C. Although TFAP2A KO did not lead to a drastic downregulation of the APA+ progenitor amount and expression of the other TEtra TFs, it led to similar perturbations of GCM1, VGLL1, and OCT4, as noted for the KO of GATA3. Further combinatorial TEtra gene KO and overexpression studies should reveal the finer details of the architecture of this gene-regulatory network and the connectivity to placental genes.
Rather unexpectedly, we noted up-regulation of CDX2 in BMP4-treated GATA3 and TFAP2A KO cells, even though we observed binding of all TEtra members in the same intronic region of the gene that was previously described to be activated by GATA3 and TFAP2C in the mouse (46, 48) . It appears thus that varying the stoichiometric ratios of the TEtra effect the output of CDX2, or, alternatively, the TEtra regulate an unknown factor that suppresses CDX2, forming so-called "incoherent feedforward loop" (Fig. 6B) , which is often seen in developmental gene networks (60) . Importantly, because up-regulation of CDX2 in GATA3 KO did not rescue the ablation of the APA+ progenitors, this argues against its critical role in human TE specification.
Importantly, we provide evidence that the down-regulation of OCT4 and pluripotency is mechanistically linked to the upregulation of the TEtra (Fig. 6B) . This is based on the observations that these processes take place during the relatively short phase of APA+ progenitor specification, that the TEtra bind in the first intron of OCT4, and on the phenotype of GATA3 and TFAP2A KO that leads to weaker OCT4 down-regulation during differentiation (Figs. 4E and 5D ). We speculate that TEtra promote the formation of a repressive complex on this unique site in OCT4, which has not reported in the mouse, and that the inhibition of OCT4 could be connected to the activation of the placental hormone hGC during BMP4-induced differentiation (61) . Additional experiments are warranted to reveal the precise mechanism.
In line with previous findings that early developmental and later tissue-specific genes exhibit distinct chromatin configurations (38), we further observed that the majority of the earliest BMP4-induced genes (including TEtra) are bivalent with HCPs and hypomethylated CpGs in undifferentiated cells, while the genes from the late group (e.g., hCG) are respectively H3K27me3/H3K4me3 double negative with LCPs and hypermethylated CpGs. Somewhat unexpectedly, we did not detect significant changes in DNA methylation and acquisition of H3K4me3 mark in late up-regulated genes with LCP, arguing that the transcriptional induction can precede epigenetic changes during human ESC differentiation (Fig. 6C) .
Taken together, we predict that our validation of the APA+ progenitor cells as a model for studying the biology of human TE in vitro and our discoveries of the TEtra gene-regulatory network lay a foundation for understanding the mechanisms of human placental development and pathologies related to placental dysfunction. Furthermore, we point out important features of regulation of pluripotency dissolution and TE specification that could be unique to human and primates, thus opening a path to understand the evolution of the placenta from a developmental perspective.
Materials and Methods
The H9 (WA09) hESC line was cultured on irradiated mouse embryonic fibroblasts (MEFs) in hESC medium (DMEM/F12; 11320074; Life Technologies), supplemented with 20% KSR (10828028; Thermo Fisher Scientific), Glutamax (35050038; Life Technologies), nonessential amino acids (1140050; Thermo Fisher Scientific), β-mercaptoethanol (31350-010; Thermo Fisher Scientific), 10 ng/mL FGF2 (100-18B; Peprotech), and 1% penicillin-streptomycin (15140122; Thermo Fisher Scientific), or on Geltrex-coated (A1413202; Life Technologies) plates with mTeSR1 medium (05850; STEMCELL Technologies). Colonies were passaged by treatment with 2 mg/mL collagenase IV (17104019; Thermo Fisher Scientific) in DMEM/F12 medium for 30-45 min. HUES9 iCRISPR and H9-GATA3 lines were cultured in mTeSR1 medium in plates coated with Matrigel (356234; BD Biosciences).
Multiple preovulatory follicles from rhesus macaque females of average maternal age (∼8 y old) were obtained via controlled ovarian stimulation from the Oregon National Primate Research Center (ONPRC) Assisted Reproductive Technologies (ART) Core according to the Institutional Animal Care and Use Committee (IACUC) approved protocol #0095 entitled "Assisted Reproduction in Macaques." The IACUC is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and Oregon Health & Science University (OHSU)/ONPRC has an Animal Welfare Assurance on file with the NIH Office for Laboratory Animal Welfare (OLAW; #A3304-01).
